Article Details
Retrieved on: 2025-01-08 21:12:10
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses PostEra's expanded AI-driven drug discovery partnership with Pfizer, leveraging AI platform Proton to accelerate advancements in therapeutics, notably antibody-drug conjugates, emphasizing the collaboration's significant R&D advancements in the US.
Article found on: www.pharmtech.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here